Teva Pharmaceutical Industries Limited TEVA and its partner, Biolojic Design Ltd., announced that TEVA has initiated investigational new drug or IND-enabling studies on BD9, a dual-specific ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter ...

Save your free seat now. Teva Pharmaceutical Industries Ltd TEVA and Biolojic Design Ltd announced that Teva initiated IND-enabling studies with BD9, a dual-specific multibody targeting both TSLP ...

With Teva entering the next stage of its sweeping restructuring plan, thousands of employees are slated to be let go from the hybrid generics and innovative medicines giant. As part of a new bid ...

Despite the lack of cautious enthusiasm from retail investors in Teva, it continues to beat consensus estimates by wide margins and has once again raised its 2025 financial guidance. I highlight ...

Truist Securities launched its coverage of Teva Pharmaceutical (NYSE:TEVA) with a Buy recommendation on Wednesday, citing its long-term growth strategy as the generic drugmaker prepares to host ...

Now, the FDA has said it will carry out a speedy review of a Teva medicine that it hopes can change that. The US regulator has awarded fast-track status for TEV-53408, an anti-IL-15 antibody ...

REHOVOT, Israel and WASHINGTON and TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) and Biolojic Design Ltd. ("Biolojic”), a biotechnology ...

TEL AVIV, Israel, May 22, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it is increasing the maximum tender amount of its tender offer ...

“Teva is driven by a commitment to innovation and this latest achievement gets us one step closer to providing promising, innovative treatment options for patients with chronic autoimmune ...

JERUSALEM, May 7 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported a larger than expected rise in first-quarter profit, helped by strong sales gains for a trio of its ...